ConductScience.org, home

Paper33092083

A Methylation-Based Reclassification of Bladder Cancer Based on Immune Cell Genes.

Luo Q and 1 other. Cancers (Basel), 2020. Cited by 31 papers, by iCite.

Cite this record

ConductScience Library. A Methylation-Based Reclassification of Bladder Cancer Based on Immune Cell Genes. Papers, record 33092083. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/33092083

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
A Methylation-Based Reclassification of Bladder Cancer Based on Immune Cell Genes.
PubMed
Journal
Cancers (Basel)
PubMed
Year
2020
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
31
iCite
Relative citation ratio, by iCite
1.29
iCite
Revised in PubMed
2020-10-31
PubMed

Authors2

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Luo QQizhanhttps://orcid.org/0000-0002-9390-9138
2Vögeli TAThomas-Alexander

Source PubMed

Download CSV of authors

Topics0

NLM's MeSH indexing of the paper, its major topics first.

None in this release.

References103

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
131329578Aberrant DNA methylation defines isoform usage in cancer, with functional implications.PLoS Comput Biol2019https://conductscience.org/library/papers/31329578PubMed
223724867Nivolumab plus ipilimumab in advanced melanoma.N Engl J Med2013https://conductscience.org/library/papers/23724867PubMed
323760024Cancer as a dysregulated epigenome allowing cellular growth advantage at the expense of the host.Nat Rev Cancer2013https://conductscience.org/library/papers/23760024PubMed
428487507Transcriptional regulation of FOXP3 requires integrated activation of both promoter and CNS regions in tumor-induced CD8+ Treg cells.Sci Rep2017https://conductscience.org/library/papers/28487507PubMed
517524139Expression of CD80 and CD86 costimulatory molecules are potential markers for better survival in nasopharyngeal carcinoma.BMC Cancer2007https://conductscience.org/library/papers/17524139PubMed
631901979Genome-wide somatic copy number alteration analysis and database construction for cervical cancer.Mol Genet Genomics2020https://conductscience.org/library/papers/31901979PubMed
731349879Epigenetic alterations are associated with tumor mutation burden in non-small cell lung cancer.J Immunother Cancer2019https://conductscience.org/library/papers/31349879PubMed
811325821Accelerated age-related CpG island methylation in ulcerative colitis.Cancer Res2001https://conductscience.org/library/papers/11325821PubMed
931443960European Association of Urology Guidelines on Non-muscle-invasive Bladder Cancer (TaT1 and Carcinoma In Situ) - 2019 Update.Eur Urol2019https://conductscience.org/library/papers/31443960PubMed
1025584002Safety and survival with GVAX pancreas prime and Listeria Monocytogenes-expressing mesothelin (CRS-207) boost vaccines for metastatic pancreatic cancer.J Clin Oncol2015https://conductscience.org/library/papers/25584002PubMed
1126263854Chronic inflammation in urothelial bladder cancer.Virchows Arch2015https://conductscience.org/library/papers/26263854PubMed
1211016622Fields of aberrant CpG island hypermethylation in Barrett's esophagus and associated adenocarcinoma.Cancer Res2000https://conductscience.org/library/papers/11016622PubMed
1322210181Inflammation and immune surveillance in cancer.Semin Cancer Biol2012https://conductscience.org/library/papers/22210181PubMed
1429107330Allele-Specific HLA Loss and Immune Escape in Lung Cancer Evolution.Cell2017https://conductscience.org/library/papers/29107330PubMed
1527068943Homing to solid cancers: a vascular checkpoint in adoptive cell therapy using CAR T-cells.Biochem Soc Trans2016https://conductscience.org/library/papers/27068943PubMed
1630594216Classification of triple-negative breast cancers based on Immunogenomic profiling.J Exp Clin Cancer Res2018https://conductscience.org/library/papers/30594216PubMed
1720021206Evaluation of a hepatitis B vaccination program in Taiwan: impact on hepatocellular carcinoma development.Future Oncol2010https://conductscience.org/library/papers/20021206PubMed
1828282548Attenuated in vitro effects of IFN-α, IL-2 and IL-12 on functional and receptor characteristics of peripheral blood lymphocytes in metastatic melanoma patients.Cytokine2017https://conductscience.org/library/papers/28282548PubMed
1921376230Hallmarks of cancer: the next generation.Cell2011https://conductscience.org/library/papers/21376230PubMed
2026952546Atezolizumab in patients with locally advanced and metastatic urothelial carcinoma who have progressed following treatment with platinum-based chemotherapy: a single-arm, multicentre, phase 2 trial.Lancet2016https://conductscience.org/library/papers/26952546PubMed

See all 103 referencesDownload CSV of references

Cited by29

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 31 citations.

PMIDTitleJournalYearIn PapersSource
42792838Molecular Classifications and Candidate Biomarkers for Personalizing BCG Therapy in Non-Muscle-Invasive Bladder Cancer.Biomedicines2026https://conductscience.org/library/papers/42792838PubMed
40918525Epigenetic regulation of bladder cancer in the context of aging.Front Pharmacol2025https://conductscience.org/library/papers/40918525PubMed
40890473Fatty acid-binding proteins as potential biomarkers for human cancer prognosis.Sci Rep2025https://conductscience.org/library/papers/40890473PubMed
40693457Integrative Analysis Reveals the Prognostic Effects of Epigenetic Regulators in Bladder Cancer.Cancer Med2025https://conductscience.org/library/papers/40693457PubMed
39554534Construction and validation of transcription‑factor‑based prognostic signature for TACE non‑response and characterization of tumor microenvironment infiltration in hepatocellular carcinoma.Oncol Lett2025https://conductscience.org/library/papers/39554534PubMed
38639057VDR is a potential prognostic biomarker and positively correlated with immune infiltration: a comprehensive pan-cancer analysis with experimental verification.Biosci Rep2024https://conductscience.org/library/papers/38639057PubMed
38281298Comprehensive analysis of co-expressed genes with TDP-43: prognostic and therapeutic potential in lung adenocarcinoma.J Cancer Res Clin Oncol2024https://conductscience.org/library/papers/38281298PubMed
37986009Identifying individualized prognostic signature and unraveling the molecular mechanism of recurrence in early-onset colorectal cancer.Eur J Med Res2023https://conductscience.org/library/papers/37986009PubMed
37704682FAM3 family genes are associated with prognostic value of human cancer: a pan-cancer analysis.Sci Rep2023https://conductscience.org/library/papers/37704682PubMed
37453971Improved prediction of prognosis and therapy response for lung adenocarcinoma after identification of DNA-directed RNA polymerase-associated lncRNAs.J Cancer Res Clin Oncol2023https://conductscience.org/library/papers/37453971PubMed
37400791Optimized screening of DNA methylation sites combined with gene expression analysis to identify diagnostic markers of colorectal cancer.BMC Cancer2023https://conductscience.org/library/papers/37400791PubMed
37224123Correlation between chromatin epigenetic-related lncRNA signature (CELncSig) and prognosis, immune microenvironment, and immunotherapy in non-small cell lung cancer.PLoS One2023https://conductscience.org/library/papers/37224123PubMed
36440228Construction and validation of an immune-related genes prognostic index (IRGPI) model in colon cancer.Front Endocrinol (Lausanne)2022https://conductscience.org/library/papers/36440228PubMed
36275774A novel hypoxia- and lactate metabolism-related signature to predict prognosis and immunotherapy responses for breast cancer by integrating machine learning and bioinformatic analyses.Front Immunol2022https://conductscience.org/library/papers/36275774PubMed
36211333Comprehensive analyses of a tumor-infiltrating lymphocytes-related gene signature regarding the prognosis and immunologic features for immunotherapy in bladder cancer on the basis of WGCNA.Front Immunol2022https://conductscience.org/library/papers/36211333PubMed
35978819Identified Gefitinib Metabolism-Related lncRNAs can be Applied to Predict Prognosis, Tumor Microenvironment, and Drug Sensitivity in Non-Small Cell Lung Cancer.Front Oncol2022https://conductscience.org/library/papers/35978819PubMed
35858908Identification of biomarkers related to neutrophils and two molecular subtypes of systemic lupus erythematosus.BMC Med Genomics2022https://conductscience.org/library/papers/35858908PubMed
35840985Heparanase is a prognostic biomarker independent of tumor purity and hypoxia based on bioinformatics and immunohistochemistry analysis of esophageal squamous cell carcinoma.World J Surg Oncol2022https://conductscience.org/library/papers/35840985PubMed
35669882Multiomics Data Analysis and Identification of Immune-Related Prognostic Signatures With Potential Implications in Prognosis and Immune Checkpoint Blockade Therapy of Glioblastoma.Front Neurol2022https://conductscience.org/library/papers/35669882PubMed
35592250OAS3 is a Co-Immune Biomarker Associated With Tumour Microenvironment, Disease Staging, Prognosis, and Treatment Response in Multiple Cancer Types.Front Cell Dev Biol2022https://conductscience.org/library/papers/35592250PubMed

See all 29 cited byDownload CSV of cited by

Genes51

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
AKNA80709PubTator's text mininghttps://conductscience.org/library/genes/80709NCBI Gene
APC324PubTator's text mininghttps://conductscience.org/library/genes/324NCBI Gene
ATIC471PubTator's text mininghttps://conductscience.org/library/genes/471NCBI Gene
C3AR1719PubTator's text mininghttps://conductscience.org/library/genes/719NCBI Gene
CD19930PubTator's text mininghttps://conductscience.org/library/genes/930NCBI Gene
CD27429126PubTator's text mininghttps://conductscience.org/library/genes/29126NCBI Gene
CD27680381PubTator's text mininghttps://conductscience.org/library/genes/80381NCBI Gene
CD28940PubTator's text mininghttps://conductscience.org/library/genes/940NCBI Gene
CD4920PubTator's text mininghttps://conductscience.org/library/genes/920NCBI Gene
CD80941PubTator's text mininghttps://conductscience.org/library/genes/941NCBI Gene
CD86942PubTator's text mininghttps://conductscience.org/library/genes/942NCBI Gene
CD8A925PubTator's text mininghttps://conductscience.org/library/genes/925NCBI Gene
CDC78317PubTator's text mininghttps://conductscience.org/library/genes/8317NCBI Gene
CDH1999PubTator's text mininghttps://conductscience.org/library/genes/999NCBI Gene
CDH131012PubTator's text mininghttps://conductscience.org/library/genes/1012NCBI Gene
CHST1255501PubTator's text mininghttps://conductscience.org/library/genes/55501NCBI Gene
CLTB1212PubTator's text mininghttps://conductscience.org/library/genes/1212NCBI Gene
CSF1R1436PubTator's text mininghttps://conductscience.org/library/genes/1436NCBI Gene
CSF3R1441PubTator's text mininghttps://conductscience.org/library/genes/1441NCBI Gene
CTLA41493PubTator's text mininghttps://conductscience.org/library/genes/1493NCBI Gene

See all 51 genesDownload CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/33092083

GET https://conductscience.org/api/papers/v1/33092083/references?page=2